Cognitive Behavioral Intervention for Caregiver Stress Syndrome
(ENCODE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to assist caregivers of patients with Alzheimer's or related dementias in managing the stress of pain management through a program called ENCODE (Empowering Caregivers of Patients with Dementia). Caregivers will either receive standard hospice care with supportive video calls or participate in the ENCODE intervention, which includes three video sessions focused on identifying and solving pain management challenges. Ideal participants are family caregivers concerned about managing their loved one's pain who can speak and read English. As an unphased trial, this study provides caregivers with a unique opportunity to gain valuable skills and support in managing their loved one's pain.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the ENCODE intervention is safe for caregivers?
Research has shown that programs like ENCODE, designed to assist caregivers of people with dementia, are generally safe and well-received. These programs typically emphasize teaching, support, and problem-solving instead of medications, thereby avoiding side effects. For instance, an educational program called "The Empowered Caregiver" demonstrated good results without reports of harm. This suggests that participants in the ENCODE program might benefit without major safety concerns. By using video sessions to address caregiving challenges, it aligns with other proven and safe support programs for caregivers.12345
Why are researchers excited about this trial?
Researchers are excited about the ENCODE intervention for caregiver stress syndrome because it offers a structured, problem-solving approach specifically tailored for caregivers of patients with Alzheimer's Disease and Related Dementias (ADRD). Unlike traditional support methods that primarily focus on emotional support, ENCODE involves manualized curriculum sessions that actively address caregivers' pain management challenges and concerns. This targeted, solution-oriented strategy aims to empower caregivers with practical skills to manage stress, potentially leading to improved well-being in a shorter timeframe.
What evidence suggests that the ENCODE intervention is effective for caregiver stress syndrome?
Research has shown that cognitive behavioral therapy (CBT), a component of the ENCODE program, effectively reduces depression, anxiety, and stress in caregivers of dementia patients. In this trial, participants in the ENCODE Group will receive this intervention. Similar programs have also lessened caregiver burden and reduced depressive symptoms while boosting self-confidence. The ENCODE program specifically aids caregivers in addressing pain management through clear, step-by-step problem-solving. This method, based on empowerment theory, has improved caregivers' knowledge and skills in managing dementia-related challenges. These findings suggest that ENCODE could support caregivers of patients with Alzheimer's Disease and related dementias.678910
Are You a Good Fit for This Trial?
This trial is for family or informal caregivers of hospice patients with Alzheimer's or related dementias who are at least 18 years old, speak English, have at least a 6th-grade education level, and are concerned about managing their care recipient's pain. Caregivers should not have significant cognitive impairment or hearing loss that prevents telephone conversations.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Caregivers receive the ENCODE intervention or attention control intervention through three weekly video-conferencing sessions
Follow-up
Participants are monitored for changes in caregiver quality of life, anxiety, depression, and patient pain
What Are the Treatments Tested in This Trial?
Interventions
- ENCODE
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor